US OK's EndoGastric's transoral technology:
This article was originally published in Clinica
Executive Summary
Representing its US market debut, EndoGastric Solutions has received FDA clearance for its transoral StomaphyX device for "incisionless" tissue approximation and ligation in the gastrointestinal tract. The Redmond, Washington firm, which is involved in modifying current open surgical and/or laparoscopic approaches by using transoral access instead of abdominal incisions, already markets the product in Europe.